Yomogi capsules Australia - English - Department of Health (Therapeutic Goods Administration)

yomogi capsules

prinz herget pty ltd t/a natural therapy imports - saccharomyces cerevisiae (boulardii) -

MUTAFLOR Escherichia coli strain Nissle 1917 not less than 250 million CFU enteric, capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mutaflor escherichia coli strain nissle 1917 not less than 250 million cfu enteric, capsule blister pack

prinz herget pty ltd t/a natural therapy imports - escherichia coli strain nissle 1917, quantity: 0.25 billion cfu - capsule, enteric - excipient ingredients: triethyl citrate; macrogol 4000; titanium dioxide; iron oxide red; glycerol; shellac; white beeswax; maltodextrin; carnauba wax; purified talc; methacrylic acid copolymer; potable water; gelatin; sodium lauryl sulfate - for the relief and management of chronic constipation.,increases the number of bowel movements per day and the number of days on which bowel movements occur in patients with chronic constipation.

Yomogi capsules Australia - English - Department of Health (Therapeutic Goods Administration)

yomogi capsules

prinz herget pty ltd t/a natural therapy imports - saccharomyces cerevisiae (boulardii), quantity: 250 million cfu - capsule, hard - excipient ingredients: gelatin; sodium laureth sulfate; iron oxide yellow; lactose; titanium dioxide; chlorophyll-copper complexes; magnesium stearate; purified water - decrease/reduce/relieve diarrhoea ; helps reduce occurrence of diarrhoea ; helps decrease/reduce/relieve symptoms of traveller's diarrhoea ; helps reduce occurrence of symptoms of traveller's diarrhoea ; helps maintain/support good/beneficial/friendly gut flora during antibiotic use ; help restore good/beneficial/friendly gut flora after antibiotic use ; maintain/support gastrointestinal system health ; maintain/support healthy immune system function ; maintain/support healthy gastrointestinal immune function

Azarga New Zealand - English - Medsafe (Medicines Safety Authority)

azarga

novartis new zealand ltd - brinzolamide 10 mg/ml (a 2% overage is applied during manufacture);  ; timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base;   - eye drops, suspension - 1%/0.5% - active: brinzolamide 10 mg/ml (a 2% overage is applied during manufacture)   timolol maleate 6.8 mg/ml equivalent to 5 mg/ml (0.5%) timolol as free base   excipient: benzalkonium chloride carbomer disodium edetate hydrochloric acid mannitol purified water sodium chloride sodium hydroxide tyloxapol - azarga is indicated for the decrease of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension for whom monotherapy with either component provides insufficient iop reduction

DILTIAZEM TEVA 30 MG Israel - English - Ministry of Health

diltiazem teva 30 mg

teva israel ltd - diltiazem hydrochloride - tablets - diltiazem hydrochloride 30 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

DILTIAZEM TEVA 60 MG Israel - English - Ministry of Health

diltiazem teva 60 mg

teva pharmaceutical industries ltd, israel - diltiazem hydrochloride - tablets - diltiazem hydrochloride 60 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

GANFORT PF 0.3/5  bimatoprost 0.3 mg/mL and timolol (as maleate) 5.0 mg/mL eye drops Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort pf 0.3/5 bimatoprost 0.3 mg/ml and timolol (as maleate) 5.0 mg/ml eye drops

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; hydrochloric acid; citric acid monohydrate; purified water; sodium chloride; sodium hydroxide - ganfort pf 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

GANFORT 0.3/5 bimatoprost 0.3 mg/mL & timolol (as maleate) 5.0 mg/mL eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ganfort 0.3/5 bimatoprost 0.3 mg/ml & timolol (as maleate) 5.0 mg/ml eye drops bottle

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride - ganfort eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

VIZO-PF BIMATOTIM 0.3/5 Australia - English - Department of Health (Therapeutic Goods Administration)

vizo-pf bimatotim 0.3/5

aft pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: sodium chloride; water for injections; dibasic sodium phosphate heptahydrate; citric acid monohydrate; hydrochloric acid; sodium hydroxide - vizo-pf bimatotim 0.3/5 eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy

PRINZIDE TABLET Canada - English - Health Canada

prinzide tablet

merck canada inc - lisinopril; hydrochlorothiazide - tablet - 20mg; 12.5mg - lisinopril 20mg; hydrochlorothiazide 12.5mg - angiotensin-converting enzyme inhibitors